Shanghai biomedical industry scale of 386.8 billion yuan in the first half of the year, this year was approved a few Class 1 domestic innovative drugs?

Up to now, Shanghai has been approved three Class 1 domestic innovative drugs this year (Fuhong Hanklin's srulizumab injection, Lepu Bio's protelizumab injection, and Hualing Pharmaceuticals' doxorubicin tablets), which is temporarily ranked first in the country.

There are 6 new medical device products listed through the National Innovation Special Approval Procedure (Microcardio's straight-tube thoracic aortic overlay stent system, Microcardio's laparoscopic endoscopic surgical system, Anhan Medical's GI vibrating capsule system, Lianshi Intelligence's CT image-aided diagnostic software for intracranial hemorrhage, Lianshi Medical's magnetic **** vibration imaging system, and Aipoqiang's proton therapy system. ).